EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Revolutionizing ESCC prognosis: the efficiency of tumor-infiltrating immune cells (TIIC) signature score

Haixia Wang, Shaowei Ma, Zixin Yang, Ren Niu, Haiyong Zhu, Shujun Li, Shaolin Gao, Zhirong Li, Yanhua Tian

Discover Oncology · 20.01.2025 · 16 (1)

DOI: 10.1007/s12672-024-01709-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 20.01.2025. Verfasst von Haixia Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Fifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou People's Hospital, Zhengzhou,…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients suffer from esophageal squamous cell carcinoma (ESCC), which is the ninth highly aggressive malignancy. Tumor-infiltrating immune cells (TIIC) exert as major component of the tumor microenvironment (TME), showing possible prognostic value in ESCC.

Methods

Transcriptome data and scRNA-seq data of ESCC samples were extracted from the GEO and TCGA databases. Tissue Specific Index (TSI) was defined to identify potential TIIC-RNAs from the TME. Twenty machine learning algorithms were further applied to evaluate the prognostic efficacy of TIIC signature score. Gene colocalization analysis was performed. Differences in CNV on chromosomes and SNP sites of prognostic model genes were calculated.

Results

The most reliable model of TIIC signature score was developed based on three prognostic TIIC-RNAs. It showed a higher C-index than any other reported prognostic models. ESCC patients with high TIIC signature score showed poorer survival outcomes than low TIIC signature score. The activity of most immune cells decreased with the increase of TIIC score. TIIC signature score showed difference in the expression levels and methylation levels of DEGs. There was also significant different correlation with the degree of CNV amplification and CNV deletion of the immune checkpoint genes. Gene colocalization analysis showed two prognostic model genes (ATP6V0E1 and BIRC2). MR analysis found that rs148710154 and rs75146099 SNP sites of TIIC-RNA gene had a significant correlation between them gastro-oesophageal reflux and ESCC.

Conclusion

TIIC signature score was the first time developed which provided a novel strategy and guidance for the prognosis and immunotherapy of ESCC. It also gave the evidence in the important role of immune cells from the TME in the treatment of cancers.

Schlagwörter

Stichwörter der Autor:innen

Esophageal squamous cell carcinoma (ESCC)PrognosisTumor microenvironmentTumor-infiltrating immune cells (TIIC)

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Fifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou People's Hospital, Zhengzhou, 450003, China.
  • Department of Gastrointestinal Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
  • Second Department of Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
  • Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
  • Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China. gaoshaolinHB2H@163.com.
  • Clinical Laboratory Center, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China. lzr726@126.com.

Förderung

  • Hebei Province Science and Technology Support Program

Zitieren

APA

Wang, H., Ma, S., Yang, Z., Niu, R., Zhu, H., Li, S., Gao, S., Li, Z., & Tian, Y. (2025). Revolutionizing ESCC prognosis: the efficiency of tumor-infiltrating immune cells (TIIC) signature score. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-024-01709-3

Vancouver

Wang H, Ma S, Yang Z, Niu R, Zhu H, Li S, et al. Revolutionizing ESCC prognosis: the efficiency of tumor-infiltrating immune cells (TIIC) signature score. Discover Oncology. 2025;16(1). doi:10.1007/s12672-024-01709-3

BibTeX
@article{Wang2025,
  author = {Wang, Haixia and Ma, Shaowei and Yang, Zixin and Niu, Ren and Zhu, Haiyong and Li, Shujun and Gao, Shaolin and Li, Zhirong and Tian, Yanhua},
  title = {Revolutionizing ESCC prognosis: the efficiency of tumor-infiltrating immune cells (TIIC) signature score},
  journal = {Discover Oncology},
  year = {2025},
  volume = {16},
  number = {1},
  doi = {10.1007/s12672-024-01709-3}
}
Kostenlos starten →